stock-detail (LBIO)

Oncology Corporate Profile

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
LN-145(TIL) tumor infiltrating lymphocytesCervical cancerII
LN-145(TIL) tumor infiltrating lymphocytesHead & Neck cancerII
NCI/Lion Bio (+ TBI)(TIL) tumor infiltrating lymphocytesMelanomaII
NCI/Lion Bio (+ pembrolizumab)(TIL) tumor infiltrating lymphocytesMelanomaII
Moffitt/Lion Bio (+ ipi)(TIL) tumor infiltrating lymphocytesMelanomaII
LN-144(TIL) tumor infiltrating lymphocytesMetastatic MelanomaII
NCI/Lion Bio (+ nivolumab)(TIL) tumor infiltrating lymphocytesOcular MelanomaII
Moffitt/Lion Bio (+ nivolumab)(TIL) tumor infiltrating lymphocytesMelanomaI
MD Anderson/Lion Bio(TIL) tumor infiltrating lymphocytesOvarian cancerI
MD Anderson/Lion Bio(TIL) tumor infiltrating lymphocytesPancreatic cancerI
MD Anderson/Lion Bio(TIL) tumor infiltrating lymphocytesSarcomaI

Recent News Headlines

8/21/2017 06:20 am

8/21/2017 06:20 am

8/21/2017 06:20 am

8/21/2017 06:20 am

7/25/2017 06:18 am

7/25/2017 06:18 am

7/25/2017 06:18 am

7/25/2017 06:18 am

6/28/2017 12:18 am

6/28/2017 12:18 am

6/28/2017 12:18 am

6/28/2017 12:18 am

6/27/2017 06:18 am

6/27/2017 06:18 am

6/27/2017 06:18 am

6/27/2017 06:18 am

6/13/2017 06:18 am

6/12/2017 12:18 pm

6/12/2017 12:18 pm

6/12/2017 06:18 am

6/9/2017 06:18 pm

6/9/2017 06:18 pm

6/9/2017 06:18 pm

6/9/2017 06:18 am

6/9/2017 06:18 am